Insider Selling: China Biologic Products Director Sells 2,524 Shares of Stock (CBPO)
China Biologic Products (NASDAQ:CBPO) Director Wenfang Liu unloaded 2,524 shares of the company’s stock on the open market in a transaction dated Thursday, September 12th. The stock was sold at an average price of $25.00, for a total transaction of $63,100.00. Following the sale, the director now directly owns 4,976 shares in the company. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of China Biologic Products (NASDAQ:CBPO) traded up 4.12% during mid-day trading on Monday, hitting $25.26. The stock had a trading volume of 14,667 shares. China Biologic Products has a 52-week low of $9.41 and a 52-week high of $31.15. The stock’s 50-day moving average is $24.51 and its 200-day moving average is $24.98. The company has a market cap of $680.8 million and a P/E ratio of 13.25.
China Biologic Products, Inc is a biopharmaceutical company and through its Chinese subsidiaries, Shandong Taibang and Qianfeng, and Huitian, the Company is engaged in the research, development and manufacturing of plasma-based pharmaceutical products in China.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.